B Cell-Derived Extracellular Vesicles Reveal Residual B Cell Activity in Kidney Graft Recipients Undergoing Pre-Transplant Desensitization

0301 basic medicine Medicine (General) B cells Plasma cells Cèl·lules B Trasplantament renal desensitization kidney transplantation exosomes Desensitization HLA-incompatibility Extracellular vesicles (EV) Exosomes plasma cells 3. Good health Kidney transplantation 03 medical and health sciences R5-920 Antígens HLA extracellular vesicles (EV) Energia exosomàtica Medicine HLA histocompatibility antigens Exosomatic energy
DOI: 10.3389/fmed.2021.781239 Publication Date: 2021-12-16T12:37:18Z
ABSTRACT
Background: Living-donor kidney transplant (LDKT) recipients undergoing desensitization for Human Leukocyte Antigen (HLA)-incompatibility have a high risk of developing antibody-mediated rejection (ABMR). The purpose the study is to evaluate if residual B cell activity after could be estimated by presence circulating cell-derived extracellular vesicles (BEVs). Methods: BEVs were isolated Sepharose-based size exclusion chromatography and defined as CD19+ HLA-II+ vesicles. We analyzed stored serum samples from positive crossmatch LDKT before at first post-transplant biopsy 12-month protocol (n = 11). Control groups formed hypersensitized patients who not submitted 10) low-risk 9). A prospective validation cohort 11 also included analysis cells subpopulations in recipients' blood lymph nodes recovered upon graft implantation, along with desensitization. Results: found out that HLA-II+BEVs dropped significantly relapse later developed ABMR was evident. validated these findings proof-of-concept 6 received same control group 5 recipients. In patients, studied implantation. confirmed significant drop this paralleled reduction CD19+cells nodes, while peripheral cells, change almost undetectable. Conclusions: reflected valid surrogate humoral alloreactivity setting.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (5)